QQ客服 官方微博 反馈留言

	A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation
	Li, MF; Yang, JL; Zhang, LH; Tu, SF; Zhou, X; Tan, Z; Zhou, WJ; He, YJ; Li, YH
刊名	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
	2019
卷号	Vol.38
关键词	Epidermal growth factor receptor (EGFR) Epidermal growth factor receptor pathway substrate 8 (Eps8) Breast cancer NSCLC small-molecule inhibitor
ISSN号	1756-9966
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4748859
专题	湖南大学
作者单位	1.Southern Med Univ, Zhujiang Hosp, Dept Hematol, 253 GongyeDadaoZhong, Guangzhou 510282, Guangdong, Peoples R China 2.Hunan Univ, Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China
推荐引用方式 GB/T 7714	Li, MF,Yang, JL,Zhang, LH,et al. A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation[J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,2019,Vol.38.
APA	Li, MF.,Yang, JL.,Zhang, LH.,Tu, SF.,Zhou, X.,...&Li, YH.(2019).A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,Vol.38.
MLA	Li, MF,et al."A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation".JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH Vol.38(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。